- Home
- IFRX vs PODC Comparison
IFRX vs PODC Comparison
Compare IFRX & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- PODC
- Stock Information
- Founded
- IFRX 2007
- PODC 2013
- Country
- IFRX Germany
- PODC United States
- Employees
- IFRX N/A
- PODC N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- PODC
- Sector
- IFRX Health Care
- PODC
- Exchange
- IFRX Nasdaq
- PODC Nasdaq
- Market Cap
- IFRX 53.5M
- PODC 44.1M
- IPO Year
- IFRX 2017
- PODC N/A
- Fundamental
- Price
- IFRX $0.87
- PODC $2.04
- Analyst Decision
- IFRX Strong Buy
- PODC
- Analyst Count
- IFRX 4
- PODC 0
- Target Price
- IFRX $7.75
- PODC N/A
- AVG Volume (30 Days)
- IFRX 359.0K
- PODC 136.7K
- Earning Date
- IFRX 08-07-2025
- PODC 08-12-2025
- Dividend Yield
- IFRX N/A
- PODC N/A
- EPS Growth
- IFRX N/A
- PODC N/A
- EPS
- IFRX N/A
- PODC N/A
- Revenue
- IFRX $140,242.00
- PODC $52,119,000.00
- Revenue This Year
- IFRX N/A
- PODC $19.39
- Revenue Next Year
- IFRX $1,276.37
- PODC $23.41
- P/E Ratio
- IFRX N/A
- PODC N/A
- Revenue Growth
- IFRX 30.90
- PODC 20.36
- 52 Week Low
- IFRX $0.71
- PODC $1.10
- 52 Week High
- IFRX $2.82
- PODC $2.94
- Technical
- Relative Strength Index (RSI)
- IFRX 45.31
- PODC 44.62
- Support Level
- IFRX $0.82
- PODC $1.92
- Resistance Level
- IFRX $0.93
- PODC $2.37
- Average True Range (ATR)
- IFRX 0.06
- PODC 0.27
- MACD
- IFRX 0.02
- PODC -0.05
- Stochastic Oscillator
- IFRX 33.94
- PODC 6.37
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.